1 Min Read
April 17 (Reuters) - U.S. Food And Drug Administration:
* RIGEL PHARMACEUTICALS NDA FOR TAVALISSE APPROVED BY FDA Source text: (bit.ly/2HGn96a) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.